Robert Dillman, MD
Enriched profileChief Medical Officer, AIVITA Biomedical · AIVITA Biomedical
Robert Dillman is Chief Medical Officer, AIVITA Biomedical at AIVITA Biomedical. OpenAlex indexes 34 publications with 1,576 citations (h-index 14); ClinicalTrials.gov lists 23 registered studies with this person as an investigator.
Data verified 3 Nov 2026
Overview
Updated 3 Nov 2026
Robert O. Dillman, MD FACP, is Chief Medical Officer, AIVITA Biomedical. The public record shows 34 publications with 1,576 citations (h-index 14), centered on Melanoma, Lymphoma, Kidney Cancer / RCC. It also documents an investigator role on 23 registered clinical trials, 3 NIH-funded awards (1985–1989).
- Top research focus: Melanoma
- 23 registered trials on ClinicalTrials.gov
Generated from the cited public record · current as of 3 Nov 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Publications indexed by OpenAlex. Counts exclude supporting files.
Citations across these publications.
H-index from these publications.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 3 Nov 2026
Listed as an investigator on 23 registered studies on ClinicalTrials.gov. The most recent:
- AV-GBM-1 vs Control as Adjunctive Therapy Following Surgery and RT/TMZ in Newly Diagnosed GBM
Sponsor: Aivita Biomedical, Inc.
- Dendritic Cell Vaccine, AV-COVID-19, to Prevent COVID-19 Infection
Sponsor: Aivita Biomedical, Inc.
- Phase I-II Trial of Dendritic Cell Vaccine to Prevent COVID-19 in Adults
Sponsor: Aivita Biomedical, Inc.
Industry payments
No payments involving this person were reported to CMS in program years 2021–2024. Why? →
NIH funding
Updated 3 Nov 2026
3 NIH research awards on record, funded 1985–1989 per NIH RePORTER. The latest:
- PHASE I-II TRIAL OF MURINE MONOCLONAL ANTIBODY T101
University of California San Diego
FY1985M01RR000827
Publications
None on file yet. We only list publications we can confidently match to this person. Why? →
Most-cited works
by citation count (OpenAlex)- 01
- 02Antibodies as cytotoxic therapy.Article123 citations1994
- 03
- 04
- 05Perceptions of Herceptin®: A Monoclonal Antibody for the Treatment of Breast CancerArticle55 citations1999
Network
Updated 3 Nov 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 3 Nov 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/robert-dillman-md
verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗
Mentions by others
where others cite or feature them- Other
aivitabiomedical.com
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →aivitabiomedical.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 3 Nov 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- Medical degree (M.D.)
Baylor College of Medicine
verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →aivitabiomedical.com ↗ - Undergraduate degree
Stanford University
verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →aivitabiomedical.com ↗
Editorial & leadership roles
journal and society appointments- verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →aivitabiomedical.com ↗
- verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →aivitabiomedical.com ↗
- verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →aivitabiomedical.com ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →aivitabiomedical.com ↗
- Past President
International Society for Immunotherapy of Cancer
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →aivitabiomedical.com ↗ - Board Member
International Society for Immunotherapy of Cancer
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →aivitabiomedical.com ↗ - Executive Medical Director
Hoag Hospital Institute for Research and Education
verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →aivitabiomedical.com ↗ - Vice President of Oncology
Caladrius Biosciences (former)
verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →aivitabiomedical.com ↗
Awards & honors
honors on the public record- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →aivitabiomedical.com ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →aivitabiomedical.com ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →aivitabiomedical.com ↗
Secondary affiliations
appointments beyond the home institution- Clinical Professor of Medicine
University of California, Irvine
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →terrapinn.com ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
No other directory profiles share this institution yet.
Jedd Wolchok, MD
Weill Cornell Medicine
Frank Hodi, MD
Dana-Farber Cancer Institute
Keith Flaherty, MD
Massachusetts General Hospital
Omid Hamid, MD
The Angeles Clinic and Research Institute